C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
10/23/2002	EP1251175A1 Method for diversifying the chemical composition of protein produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
10/23/2002	EP1251174A1 Use of paramyxovirus vector in gene transfer into blood vessel
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2002	EP1251172A1 Wt1-interacting protein wtip
10/23/2002	EP1251171A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality
10/23/2002	EP1251170A2 Method and reagent for treatment of NF-kappaB dependent animal diseases
10/23/2002	EP1251169A1 Method for synthesizing single stranded stem-loop DNAs, the products and uses therefor
10/23/2002	EP1251168A1 Method for improving the stability of linear DNA in cell-free in vitro transcription/translation systems
10/23/2002	EP1251139A2 Human mindin-like protein and nucleic acids encoding it
10/23/2002	EP1251138A1 Prion protein dimers useful for vaccination
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1251136A2 Method and reagents for analyzing the nucleotide sequence of nucleic acids
10/23/2002	EP1250599A2 System for the internal qualitative and quantitative validation of marker indices
10/23/2002	EP1250597A2 Identification of peripheral benzodiazepine receptor binding agents
10/23/2002	EP1250463A1 Sensitive, multiplexed diagnostic assays for protein analysis
10/23/2002	EP1250462A2 Method of processing a sample containing at least one biological element
10/23/2002	EP1250461A2 Methods and kits for identifying elite event gat-zm1 in biological samples
10/23/2002	EP1250459A2 Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions
10/23/2002	EP1250458A2 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
10/23/2002	EP1250455A1 Antisense inhibition of ptp1b expression
10/23/2002	EP1250453A1 Use of multiple recombination sites with unique specificity in recombinational cloning
10/23/2002	EP1250452A1 Methods for determining single nucleotide variations and genotyping
10/23/2002	EP1250451A1 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample
10/23/2002	EP1250449A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
10/23/2002	EP1250448A2 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam)
10/23/2002	EP1250447A2 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams
10/23/2002	EP1250446A1 Replication competent herpes virus strains
10/23/2002	EP1250445A2 Tissue-specific expression of target genes in plants
10/23/2002	EP1250444A1 Methods for producing a polypeptide using a consensus translational initiator sequence
10/23/2002	EP1250443A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN C $g(m)?3 AND C $g(m)?4 DOMAINS
10/23/2002	EP1250442A2 Method for the manufacture of recombinant trypsin
10/23/2002	EP1250441A1 Ceramidase
10/23/2002	EP1250440A1 Identifying genes associated with a qtl corn digestibility locus
10/23/2002	EP1250439A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/23/2002	EP1250438A2 Therapeutic polypeptides and methods for using same
10/23/2002	EP1250437A2 Membrane-bound proteins and nucleic acids encoding the same
10/23/2002	EP1250436A1 Toll-like receptor
10/23/2002	EP1250435A2 Human neurexin-like proteins and polynucleotides encoding the same
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250433A1 Human membrane proteins and polynucleotides encoding the same
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250431A2 Modulation of gene expression in formation of fatty atherosclerotic lesions
10/23/2002	EP1250430A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof
10/23/2002	EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002	EP1250428A1 32164 protein, a novel seven transmembrane protein
10/23/2002	EP1250427A2 Human membrane proteins and polynucleotides encodingthe same having homology to cd20 proteins and ige receptors
10/23/2002	EP1250426A2 Secreted and transmembrane polypeptides and nucleic acids encoding same
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250424A1 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
10/23/2002	EP1250423A2 Pullulanase variants and methods for preparing such variants with predetermined properties
10/23/2002	EP1250421A1 Recombinant flaviviruses and methods of use thereof
10/23/2002	EP1250420A2 Techniques for growth and differentiation of human pluripotent stem cells
10/23/2002	EP1250419A2 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants
10/23/2002	EP1250418A2 Methods for identifying anti-cancer drug targets
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250356A2 POTASSIUM CHANNEL MUTANTS OF THE i SACCHAROMYCES CEREVISIAE /i YEAST AND THE USE THEREOF FOR THE SCREENING OF EUKARYOTIC POTASSIUM CHANNELS
10/23/2002	EP1250352A1 Receptor-like protein kinases from nicotiana tabacum
10/23/2002	EP1250349A2 Cardiac-cell specific enhancer elements and uses thereof
10/23/2002	EP1250348A1 Antisense modulation of daxx expression
10/23/2002	EP1250347A1 Antisense modulation of akt-3 expression
10/23/2002	EP1250157A1 Antisense modulation of inducible nitric oxide synthase expression
10/23/2002	EP1250156A1 Method for nucleic acid transfection of cells
10/23/2002	EP1250154A2 G-csf conjugates
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP1250039A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor
10/23/2002	EP1144009B1 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/23/2002	EP1070255A4 Assay of igfbp complex
10/23/2002	EP1063891A4 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/23/2002	EP0996707A4 Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof
10/23/2002	EP0925364B1 A lactic acid bacterial regulatable expression system
10/23/2002	EP0909278A4 Nephropathy-related immunoglobulin g and antibodies for same
10/23/2002	EP0880594B1 Retroviral vector and its use in gene therapy
10/23/2002	EP0858345B1 Use of muteins of wild-type cytokines as immunogens
10/23/2002	EP0771362B1 Genetic diagnosis and pharmaceutical compositions for treatment of prostate cancer
10/23/2002	EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002	EP0760011B1 Method for testing for mutations in dna from a patient sample
10/23/2002	EP0721470B1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	EP0576623B1 Binding domains in notch and delta proteins
10/23/2002	EP0502108B2 Device for processing biological specimens for analysis of nucleic acids
10/23/2002	CN1376282A Employing synthetic genes in gene algorithm, information encoding and non-replicative encryption
10/23/2002	CN1376206A Method and nucleic acid molecules for determining the presence of micro-organisms specific to the brewing process
10/23/2002	CN1376204A Flex seed specific promoters
10/23/2002	CN1376203A Transcriptionally silenced palnt genes
10/23/2002	CN1376202A Stereostructure of decarbamylase and method of using the same
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376200A DNA vaccine-PCV
10/23/2002	CN1376199A Epoxide hydrolases from streptomyces
10/23/2002	CN1376198A Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/23/2002	CN1376197A Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
10/23/2002	CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002	CN1376195A Endo-beta-N-acetyl glucosaminidase gene
10/23/2002	CN1376194A Electron donor system for enzymes and its use for the biochemical conversion of substrates
10/23/2002	CN1376165A Materials and methods for inhibition of Lg E production
10/23/2002	CN1376163A Highly purified cytokine activating factor and methods of use
10/23/2002	CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/23/2002	CN1376056A Liposome-entrapped DNA oral vaccines

1 ... 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 ... 4023